Gemcitabine and Cisplatin Chemotherapy

DRUG3 trials

Sponsors

Fudan University, Shanghai Zhongshan Hospital

Conditions

Biliary Tract Cancer (BTC)CholangiocarcinomaNasopharyngeal Carcinoma

Phase 2

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

Active, not recruitingNCT04517214

Fudan UniversityNasopharyngeal Carcinoma

Start: 2020-11-01End: 2026-12-31Target: 100Updated: 2025-04-02

QL1706（Iparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line Treatment for PD-L1-Positive Biliary Tract Cancer

RecruitingNCT07733115

Shanghai Zhongshan HospitalBiliary Tract Cancer (BTC)

Start: 2026-07-20End: 2029-12-31Target: 38Updated: 2026-07-29

Unknown Phase

Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA

RecruitingNCT07291063

Shanghai Zhongshan HospitalCholangiocarcinoma

Start: 2024-07-19End: 2029-12-31Target: 50Updated: 2025-12-18